Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what, from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 65 filings

Top spenders & firms Spend by issue Political contributions Revolving door

  Showing filings that named S 43. Clear
Clear
4T
CAPITOL HILL CONSULTING GROUP for ASSOCIATION FOR ACCESSIBLE MEDICINES (FORMERLY GENERIC PHARMACEUTICAL ASSOC.)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Trade (domestic/foreign), Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q4
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q4
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · Senate · $60,000.00 income
Pharmacy
View →
Q4
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Copyright/Patent/Trademark
View →
Q4
APOTEX CORP. for APOTEX CORP.
4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate
Manufacturing, Health Issues, Tariff (miscellaneous tariff bills)
View →
Q4
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View →
3A
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Trade (domestic/foreign), Medicare/Medicaid, Health Issues, Manufacturing
View →
Q3
AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA) for AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION (AIPLA)
3rd Quarter (July 1 - Sep 30) 2025 · Virginia · House · Senate
Copyright/Patent/Trademark
View →
Q3
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View →
Q3
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Manufacturing, Health Issues, Medicare/Medicaid, Trade (domestic/foreign)
View →
Q3
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View →
Q3
ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Pharmacy, Medicare/Medicaid, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Homeland Security
View →
Q3
NOVARTIS for NOVARTIS
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Q3
PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign), Health Issues
View →
Q3
MEHLMAN CONSULTING, INC. for ASSOCIATION OF ACCESSIBLE MEDICINES
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Medicare/Medicaid, Health Issues, Pharmacy
View →
Q3
FRESENIUS KABI USA LLC for FRESENIUS KABI USA LLC
3rd Quarter (July 1 - Sep 30) 2025 · Illinois · House · Senate
Manufacturing, Budget/Appropriations, Copyright/Patent/Trademark, Trade (domestic/foreign)
View →
Q3
MEHLMAN CONSULTING, INC. for THE CAMPAIGN FOR SUSTAINABLE RX PRICING
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Medicare/Medicaid, Pharmacy, Copyright/Patent/Trademark
View →
Q3
APOTEX CORP. for APOTEX CORP.
3rd Quarter (July 1 - Sep 30) 2025 · Florida · House · Senate
Manufacturing, Health Issues, Tariff (miscellaneous tariff bills)
View →
Q3
FIERCE GOVERNMENT RELATIONS for ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $60,000.00 income
Pharmacy
View →
Q3
INTELLECTUAL PROPERTY OWNERS ASSOCIATION for INTELLECTUAL PROPERTY OWNERS ASSOCIATION
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate
Copyright/Patent/Trademark
View →
Q2
SANOFI US SERVICES INC. for SANOFI US SERVICES INC
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Health Issues, Medicare/Medicaid, Trade (domestic/foreign), Taxation/Internal Revenue Code
View →
Q2
WHITMER & WORRALL, LLC for CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income
Medicare/Medicaid, Copyright/Patent/Trademark, Pharmacy
View →
Q2
GSK (FKA GLAXOSMITHKLINE INC.) for GSK (FKA GLAXOSMITHKLINE INC.)
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate
Budget/Appropriations, Copyright/Patent/Trademark, Health Issues, Medicare/Medicaid
View →
Previous Page 2 of 3 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem